‘Miracle’ Cystic Fibrosis Treatment For Children on The NHS
Hundreds of children are set to benefit from a ‘miracle’ treatment for cystic fibrosis, which has already changed the lives of thousands of people, the NHS has announced today.
Patients here were some of the first in Europe to benefit from Kaftrio when NHS England secured a landmark deal in June 2020.
Nine out of 10 patients with cystic fibrosis – more than 7,000 people in England – can benefit from the ‘triple therapy’, which tackles the underlying causes of the disease as well as symptoms.
Kaftrio significantly improves lung function, helping people with cystic fibrosis to breathe more easily and enhancing their overall quality of life.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has now confirmed an extension to the licence for Kaftrio, which means more than 1300 children in England with cystic fibrosis, aged six to 11, are newly eligible for this treatment.
NHS chief executive Amanda Pritchard said: “Since NHS staff delivered one of the fastest rollouts of Kaftrio in the world just over a year ago, the lives of thousands of patients with cystic fibrosis have been transformed.
“Innovative treatments like Kaftrio are life-changing for patients and their families, and that is why the NHS has done all it can since we secured the deal for Kaftrio to ensure patients benefit as soon as possible.
“The latest development will ensure hundreds of children will now be able to access this incredible treatment for the first time.
“The NHS Long Term Plan committed to using the latest cutting-edge treatments and therapies to save and improve patients’ lives, and this is the latest example of NHS England using the advanced commercial capabilities we have been given to deliver this.”
Health and Social Care Secretary Sajid Javid said: “I’m delighted that hundreds more children will receive this life-changing cystic fibrosis drug, which can give them a better quality of life for longer.
“Thanks to NHS staff, thousands of people have already benefitted as part of one of the fastest rollouts of Kaftrio in the world – and I salute them on this incredible accomplishment.”
Until now Kaftrio was only licensed for those aged 12 and above.
For almost 700 of these children it will be the first time they are able to receive one of a new generation of cystic fibrosis drugs, known as ‘modulators’.
June Raine, MHRA chief executive, said: “It’s very good news that after a rigorous review, we have approved Kaftrio for children aged six to 11, enabling the NHS to bring this life-saving treatment to more children suffering from cystic fibrosis.
“We will continue to work closely with our colleagues across the health system to help bring cutting-edge medicines to patients.”
With today’s extension to the licence the company will be able to supply the new dose of Kaftrio to the NHS in England within weeks, enabling clinicians to then prescribe to all young patients aged six to 11 where it is considered the best option for their treatment.
Cystic fibrosis is a progressive, genetic disease that causes persistent lung infections and limits the ability to breathe over time – there are around 8,000 people living with cystic fibrosis in England, which is the second highest proportion in the world.
Kaftrio, described by patient groups as a ‘revolutionary drug’, is a triple combination treatment combining three drugs which perform different functions – ivacaftor, tezacaftor and elexacaftor – and tackles the underlying causes of the disease, by helping the lungs work effectively.
The Kaftrio deal is one of a series of medicine deals made possible by the NHS’ advanced commercial capabilities, which have also secured patient access to cutting-edge one-shot gene therapies like life-saving drug Zolgensma, which can help babies with Spinal Muscular Atrophy move and walk; and the first new treatment for sickle cell disease in more than two decades.
The terms of NHS England’s deal meant that patients would automatically be entitled to access Kaftrio under all future extensions of the drug’s licence.
Latest News from
NHS Digital and NHS England complete merger02/02/2023 10:15:00
NHS England and NHS Digital yesterday legally merged in the first step towards creating a new, single organisation to lead the NHS in England to deliver high-quality services for all.
NHS to offer licensed cannabis-based medicine to treat rare genetic condition01/02/2023 11:15:00
The NHS will be able to prescribe cannabidiol to patients with a rare, seizure-causing genetic disorder in England from yesterday after the National Institute for Health and Care Excellence (NICE) issued final guidance recommending its use.
The Repair Shop marks NHS7531/01/2023 14:25:00
To help mark the NHS’s 75th anniversary, The Repair Shop is looking for unique NHS items to restore.
NHS drive to reduce ‘no shows’ to help tackle long waits for care30/01/2023 16:10:00
The NHS has this week launched a major drive to reduce hundreds of thousands of missed hospital appointments every month, to help boost the recovery of elective services.
Expansion of NHS 111 to transform patient access30/01/2023 13:05:00
Patients are set to receive an enhanced NHS 111 offer including increased access to specialist paediatric advice for children and direct access to urgent mental health support, as part of a blueprint set out today to help recover urgent and emergency care services.
Major plan to recover urgent and emergency care services30/01/2023 11:15:00
The NHS and the government will publish a new blueprint today to help recover urgent and emergency care services, reduce waiting times, and improve patient experience.
Handover delays fall despite increase in patients being taken to A&E by ambulance26/01/2023 15:15:00
Ambulance waits outside A&E reduced despite thousands more people being taken to hospital last week and continued pressures across the NHS, new figures show today.
NHS issues final call to come forward for COVID booster26/01/2023 09:15:00
The NHS is encouraging people to come forward for their COVID booster before the offer, part of the biggest and most successful programme in health history, ends next month.
NHS urges women to book a cervical screening as a third don’t take up vital offer23/01/2023 16:05:00
The NHS has issued a call for anyone eligible for cervical screening to come forward for a potentially life-saving appointment, with nearly a third, around 4.6 million, not taking up their latest test.